Clonal Studies of the JAK2 V617F Mutation in Myeloproliferative Disorders

骨髓增生性疾病中 JAK2 V617F 突变的克隆研究

• 批准号: 182063
• 负责人: Kent David G
• 金额: $ 10.93万
• 依托单位: University of Cambridge (UK)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-02-01 至 2012-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=182063&lang=en
• 关键词: Cell Signalling; Colony Assays; Cytokines; Gene Expression; Hematopoiesis; Immuno-Affinity Capillary Electrophoresis; Leukemia; Myeloproliferative Disorders; Primary Cell Culture; Stem Cells

The blood system of humans must produce and destroy billions of blood cells on a daily basis in order to keep up with the demands of the body. Sometimes this process is imperfect and incorrect numbers/types of blood cells are produced, resulting in chron

人类的血液系统每天必须产生和破坏数十亿个血细胞，以满足身体的需求。 有时这个过程是不完美的，产生了不正确的血细胞数量/类型，导致慢性病。